Skip to content

Taxes Paid at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$14.64M+41.0%
Insmed logo
InsmedINSM
$2.94M+35.1%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$1.84M+188%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$627K+56.8%
Arrowhead Research logo
Arrowhead ResearchARWR
$11.66M+16,554%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s taxes paid?
Sarepta Therapeutics, Inc. (SRPT) reported taxes paid of $1.73M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s taxes paid changed year-over-year?
Sarepta Therapeutics, Inc.'s taxes paid increased by 106.9% year-over-year, from $835K to $1.73M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s taxes paid?
Over 3 years (2021 to 2025), Sarepta Therapeutics, Inc.'s taxes paid has grown at a 301.1% compound annual growth rate (CAGR), from $583K to $37.63M.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.